التفاصيل البيبلوغرافية
| العنوان: |
Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab. |
| المؤلفون: |
Schultes, Bernd, Ernst, Barbara, Schmid, Sebastian M. |
| المصدر: |
Acta Diabetologica; Nov2021, Vol. 58 Issue 11, p1575-1577, 3p |
| مصطلحات موضوعية: |
INSULIN derivatives, DIABETES, MELAS syndrome, SUBTILISINS |
| مستخلص: |
Keywords: MIDD; PCSK9 inhibitors; Hypercholesterinemia; Arteriosclerotic cardiovascular disease; Mitochondrial EN MIDD PCSK9 inhibitors Hypercholesterinemia Arteriosclerotic cardiovascular disease Mitochondrial 1575 1577 3 10/13/21 20211101 NES 211101 This article belongs to the topical collection Pregnancy and Diabetes, managed by Antonio Secchi and Marina Scavini. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have been shown to markedly lower LDL-C levels in patients with T2DM [[4]] and could be a valuable therapeutic option also in patients with MIDD. [Extracted from the article] |
|
Copyright of Acta Diabetologica is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
